カテゴリー： 世界, 医療/バイオ, FactMR

世界の心肺負荷試験市場2023-2033：製品別（CPETシステム、ストレスECG、パルスオキシメーター、SPECT、ストレス血圧モニター）、エンドユーザー別（病院、専門クリニック/循環器科クリニック、外来手術センター、診断センター）、地域別

【英語タイトル】Cardiopulmonary Stress Testing Systems Market By Product (CPET Systems, Stress ECG, Pulse Oximeters, SPECT, Stress Blood Pressure Monitors), By End User (Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers) & Region – Global Market Insights 2023 to 2033

FactMRが出版した調査資料（FACT23AP085）・商品コード：FACT23AP085
・発行会社（調査会社）：FactMR
・発行日：2023年1月25日
・ページ数：約170
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Fact.MR社発行の最新調査レポートでは、世界の心肺負荷試験市場について2023年から2033年までの市場動向を分析・予測しています。当レポートは、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、製品別（CPETシステム、ストレスECG、パルスオキシメーター、ストレス血圧モニター）分析、エンドユーザー別（病院、専門クリニック/循環器科クリニック、外来手術センター、診断センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況など、多面的な分析結果をまとめたものです。なお、企業情報として、Koninklijke Philips N.V.、Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)、General Electric Company (GE Healthcare)などが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・世界の心肺負荷試験市場規模：製品別
　- CPETシステムの市場規模
　- ストレスECGの市場規模
　- パルスオキシメーターの市場規模
　- ストレス血圧モニターの市場規模
・世界の心肺負荷試験市場規模：エンドユーザー別
　- 病院における市場規模
　- 専門クリニック/循環器科クリニックにおける市場規模
　- 外来手術センターにおける市場規模
　- 診断センターにおける市場規模
・世界の心肺負荷試験市場規模：地域別
　- 北米の心肺負荷試験市場規模
　- ヨーロッパの心肺負荷試験市場規模
　- アジア太平洋の心肺負荷試験市場規模
　- 中南米の心肺負荷試験市場規模
　- 中東/アフリカの心肺負荷試験市場規模
・競争状況

本レポートには、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。また、購読者に実用的な洞察を提供し、熟考して市場の状況を示し、心肺負荷試験における競争レベルを推測するのに役立ちます。

Cardiopulmonary Stress Testing Systems Market – Scope of Report

A recent study by Fact.MR on the cardiopulmonary stress testing systems market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering cardiopulmonary stress testing systems.

The study also provides the dynamics responsible for influencing the future status of the cardiopulmonary stress testing systems market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the cardiopulmonary stress testing systems market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of cardiopulmonary stress testing systems across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of cardiopulmonary stress testing systems during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for cardiopulmonary stress testing systems are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global cardiopulmonary stress testing systems market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the cardiopulmonary stress testing systems market during the forecast period.

Country-specific valuation on demand for cardiopulmonary stress testing systems has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of cardiopulmonary stress testing systems, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering cardiopulmonary stress testing systems has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the cardiopulmonary stress testing systems domain.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Key Market Indicators

    4.4. Market Dynamics

        4.4.1. Drivers

            4.4.1.1. Rising awareness among end-users about accurate assessment of cardiovascular diseases due to new monitoring technologies is significantly enhancing the diagnosis rate

            4.4.1.2. Growing geriatric population propels adoption of preventive disease-monitoring products

        4.4.2. Restraints

            4.4.2.1. Shutdown of Chalk River resulting in shortage of Tc-99 m and reduction in the number of SPECT procedures

            4.4.2.2. Implementation of legal provisions that promote cost containment/cost-cutting strategies

        4.4.3. Opportunity

    4.5. Global Market Analysis and Forecasts, 2023–2033

        4.5.1. Market Revenue Projections (US$ Mn)

    4.6. Porter’s Five Force Analysis

    4.7. Market Outlook

    4.8. Regulatory Scenarios

    4.9. Cardiovascular Diseases Prevalence, by Region

    4.10. Applied SWOT Analysis

5. Global Market Analysis and Forecasts, By Product Type

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value Forecast ByProduct Type, 2023–2033

        5.4.1. Cardiopulmonary Exercise Testing (CPET) Systems

        5.4.2. Stress ECG

        5.4.3. Pulse Oximeters

        5.4.4. Stress Blood Pressure Monitors

        5.4.5. Single-Photon Emission Computed Tomography (SPECT)

    5.5. Product Type Comparison Matrix

    5.6. Market Attractiveness By Product Type

6. Global Market Analysis and Forecasts, By End-user

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value Forecast By End-user, 2023–2033

        6.4.1. Hospitals

        6.4.2. Specialty Clinics/Cardiology Clinics

        6.4.3. Ambulatory Surgical Centers

        6.4.4. Diagnostic Centers

    6.5. Market Attractiveness By End-user

7. Global Market Analysis and Forecasts, By Region

    7.1. Key Findings

    7.2. Policies and Regulations

    7.3. Market Value Forecast By Region

        7.3.1. North America

        7.3.2. Europe

        7.3.3. Asia Pacific

        7.3.4. Latin America

        7.3.5. Middle East and Africa

    7.4. Market Attractiveness By Country/Region

8. North America Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

        8.1.2. Key Trends

    8.2. Market Value Forecast By Product Type, 2023–2033

        8.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        8.2.2. Stress ECG

        8.2.3. Pulse Oximeters

        8.2.4. Stress Blood Pressure Monitors

        8.2.5. Single-Photon Emission Computed Tomography (SPECT)

    8.3. Market Value Forecast By End-user, 2023–2033

        8.3.1. Hospitals

        8.3.2. Specialty Clinics/Cardiology Clinics

        8.3.3. Ambulatory Surgical Centers

        8.3.4. Diagnostic Centers

    8.4. Market Value Forecast By Country, 2023–2033

        8.4.1. U.S.

        8.4.2. Canada

    8.5. Market Attractiveness Analysis

        8.5.1. By Product Type

        8.5.2. By End-user

        8.5.3. By Country

9. Europe Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

        9.1.2. Key Trends

    9.2. Market Value Forecast ByProduct Type, 2023–2033

        9.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        9.2.2. Stress ECG

        9.2.3. Pulse Oximeters

        9.2.4. Stress Blood Pressure Monitors

        9.2.5. Single-Photon Emission Computed Tomography (SPECT)

    9.3. Market Value Forecast By End-user, 2023–2033

        9.3.1. Hospitals

        9.3.2. Specialty Clinics/Cardiology Clinics

        9.3.3. Ambulatory Surgical Centers

        9.3.4. Diagnostic Centers

    9.4. Market Value Forecast By Country/Sub-region, 2023–2033

        9.4.1. U.K.

        9.4.2. Germany

        9.4.3. France

        9.4.4. Italy

        9.4.5. Spain

        9.4.6. Russia

        9.4.7. Rest of Europe

    9.5. Market Attractiveness Analysis

        9.5.1. By Product Type

        9.5.2. By End-user

        9.5.3. By Country/Sub-region

10. Asia Pacific Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Key Trends

    10.2. Market Value Forecast By Product Type, 2023–2033

        10.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        10.2.2. Stress ECG

        10.2.3. Pulse Oximeters

        10.2.4. Stress Blood Pressure Monitors

        10.2.5. Single-Photon Emission Computed Tomography (SPECT)

    10.3. Market Value Forecast By End-user, 2023–2033

        10.3.1. Hospitals

        10.3.2. Specialty Clinics/Cardiology Clinics

        10.3.3. Ambulatory Surgical Centers

        10.3.4. Diagnostic Centers

    10.4. Market Value Forecast By Country/Sub-region, 2023–2033

        10.4.1. India

        10.4.2. China

        10.4.3. Japan

        10.4.4. Australia & New Zealand

        10.4.5. Rest of Asia Pacific

    10.5. Market Attractiveness Analysis

        10.5.1. By Product Type

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Latin America Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Key Trends

    11.2. Market Value Forecast By Product Type, 2023–2033

        11.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        11.2.2. Stress ECG

        11.2.3. Pulse Oximeters

        11.2.4. Stress Blood Pressure Monitors

        11.2.5. Single-Photon Emission Computed Tomography (SPECT)

    11.3. Market Value Forecast By End-user, 2023–2033

        11.3.1. Hospitals

        11.3.2. Specialty Clinics/Cardiology Clinics

        11.3.3. Ambulatory Surgical Centers

        11.3.4. Diagnostic Centers

    11.4. Market Value Forecast By Country/Sub-region, 2023–2033

        11.4.1. Brazil

        11.4.2. Mexico

        11.4.3. Rest of Latin America

    11.5. Market Attractiveness Analysis

        11.5.1. By Product Type

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Middle East and Africa Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Key Trends

    12.2. Market Value Forecast By Product Type, 2023–2033

        12.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        12.2.2. Stress ECG

        12.2.3. Pulse Oximeters

        12.2.4. Stress Blood Pressure Monitors

        12.2.5. Single-Photon Emission Computed Tomography (SPECT)

    12.3. Market Value Forecast By End-user, 2023–2033

        12.3.1. Hospitals

        12.3.2. Specialty Clinics/Cardiology Clinics

        12.3.3. Ambulatory Surgical Centers

        12.3.4. Diagnostic Centers

    12.4. Market Value Forecast By Country/Sub-region, 2023–2033

        12.4.1. South Africa

        12.4.2. GCC Countries

        12.4.3. Israel

        12.4.4. Rest of Middle East and Africa

    12.5. Market Attractiveness Analysis

        12.5.1. By Product Type

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player – Competition Matrix (By Tier and Size of companies)

    13.2. Market Share Analysis By Company (2022)

    13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        13.3.1. Koninklijke Philips N.V.

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.1.2. Financial Overview

            13.3.1.3. SWOT Analysis

            13.3.1.4. Strategic Overview

        13.3.2. Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.2.2. Financial Overview

            13.3.2.3. Product Portfolio

            13.3.2.4. SWOT Analysis

            13.3.2.5. Strategic Overview

        13.3.3. General Electric Company (GE Healthcare)

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.3.2. Financial Overview

            13.3.3.3. Product Portfolio

            13.3.3.4. SWOT Analysis

            13.3.3.5. Strategic Overview

        13.3.4. MGC Diagnostics Corporation

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.4.2. Financial Overview

            13.3.4.3. Product Portfolio

            13.3.4.4. SWOT Analysis

            13.3.4.5. Strategic Overview

        13.3.5. OSI Systems, Inc. (Spacelabs Healthcare)

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.5.2. Financial Overview

            13.3.5.3. Product Portfolio.

            13.3.5.4. SWOT Analysis

            13.3.5.5. Strategic Overview

        13.3.6. Masimo

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.6.2. Financial Overview

            13.3.6.3. Product Portfolio

            13.3.6.4. SWOT Analysis

            13.3.6.5. Strategic Overview

        13.3.7. NIHON KOHDEN CORPORATION

            13.3.7.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.7.2. Financial Overview

            13.3.7.3. Product Portfolio

            13.3.7.4. SWOT Analysis

            13.3.7.5. Strategic Overview

        13.3.8. COSMED

            13.3.8.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.8.2. Financial Overview

            13.3.8.3. Product Portfolio

            13.3.8.4. SWOT Analysis

            13.3.8.5. Strategic Overview

        13.3.9. Halma plc (SunTech Medical, Inc.)

            13.3.9.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.9.2. Financial Overview

            13.3.9.3. Product Portfolio

            13.3.9.4. SWOT Analysis

            13.3.9.5. Strategic Overview

        13.3.10. Schiller AG

            13.3.10.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.10.2. Financial Overview

            13.3.10.3. Product Portfolio

            13.3.10.4. SWOT Analysis

            13.3.10.5. Strategic Overview

        13.3.11. Vyaire Medical, Inc.

            13.3.11.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.11.2. Financial Overview

            13.3.11.3. Product Portfolio

            13.3.11.4. SWOT Analysis

            13.3.11.5. Strategic Overview

Table 01: Medical Device Classification as per U.S. FDA

Table 02: Code of Federal Regulations, by Type of Device

Table 03: Supplements for Pre-market Approval, by Type of Supplement, 1986–1997

Table 04: Medical Device Classification as per European Commission (EC)

Table 05: Global Market Value (US$ Mn) Forecast, by Product Type, 2023–2033

Table 06: Global Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033

Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 09: North America Market Value (US$ Mn) Forecast, by Product Type, 2023–2033

Table 10: North America Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 11: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 12: Europe Market Value (US$ Mn) Forecast, by Product Type, 2023–2033

Table 13: Europe Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Product Type, 2023–2033

Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 17: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 18: Latin America Market Value (US$ Mn) Forecast, by Product Type, 2023–2033

Table 19: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 20: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Product Type, 2023–2033

Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023–2033

★調査レポート[世界の心肺負荷試験市場2023-2033：製品別（CPETシステム、ストレスECG、パルスオキシメーター、SPECT、ストレス血圧モニター）、エンドユーザー別（病院、専門クリニック/循環器科クリニック、外来手術センター、診断センター）、地域別] (コード：FACT23AP085)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の心肺負荷試験市場2023-2033：製品別（CPETシステム、ストレスECG、パルスオキシメーター、SPECT、ストレス血圧モニター）、エンドユーザー別（病院、専門クリニック/循環器科クリニック、外来手術センター、診断センター）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の腎臓結石管理デバイス市場2023-2033：製品タイプ別（結石破砕装置、尿管鏡、腎臓鏡）、エンドユーザー別（病院、専門クリニック、外来手術センター）、地域別
  • 世界の人工腎臓市場2023-2033：種類別（ウェアラブル型人工腎臓、埋め込み型人工腎臓）、透析別（血液透析、腹膜透析、併用療法）、用途別（成人、小児）、エンドユーザー別（病院、専門クリニック、外来手術センター）、地域別
  • 世界の遠心式血液ポンプ市場（2023-2033）：種類別（電子式、機械式）、エンドユーザー別（病院、外来手術センター、専門クリニック、その他）
  • 世界のゼラチン・骨接着剤市場（2023-2033）：製品別（ゼラチン、骨接着剤）、用途別（人工関節置換術、スポーツ障害、脊椎手術、外傷）、エンドユーザー別（病院、専門クリニック、外来手術センター）、地域別
  • 世界のハイドロサージェリー装置市場2023-2033：コンポーネント別（装置コンソール、ハンドピース、付属品）、用途別（急性創傷、慢性創傷、手術創、外傷、熱傷）、エンドユーザー別（病院、専門クリニック、外来手術センター、長期治療センター、在宅医療装置）、地域別
  • 世界の尿路カテーテル市場2023-2033：製品別（間欠カテーテル、フォーリー/留置カテーテル、外付カテーテル）、種類別（コーティング型カテーテル、非コーティング型カテーテル）、エンドユーザー別（病院、専門クリニック、外来手術センター）、用途別、地域別
  • 世界の呼吸器インターベンション市場2023-2030：製品別（気管支鏡、電磁ナビゲーション気管支鏡システム、胸腔鏡、呼吸器内治療装置、気道ステント、胸膜カテーテル、気管支内バルブ、気管支熱形成システム）、疾患別（喘息、COPD、肺がん、気管・気管支狭窄、その他）、エンドユーザー別（病院、外来手術センター、診断センター、専門クリニック、その他）、地域別
  • 世界のマルチモーダルイメージング市場（～2028年）：技術別（PET-CT、SPECT-CT、PET-MR、OCT/FMT）、用途別（腫瘍学、心臓病学、脳、眼科）、エンドユーザー別（病院、診断センター、学術、研究）、地域別
  • 世界の基底細胞がん市場2023-2033：治療タイプ別（手術、薬物、放射線治療）、エンドユーザー別（病院、専門クリニック）、地域別
  • 世界の子癇前症診断市場2022-2029：検査種類別（血液検査、尿分析）、製品別（機器、消耗品）、エンドユーザー別（病院、専門クリニック、診断センター、その他）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆